ClinVar Miner

Submissions for variant NM_017613.4(DONSON):c.670C>T (p.Pro224Ser)

gnomAD frequency: 0.00003  dbSNP: rs1028163227
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Undiagnosed Diseases Network, NIH RCV001310228 SCV001499840 pathogenic DONSON-related Meier-Gorlin syndrome 2020-02-20 criteria provided, single submitter clinical testing
Bicknell laboratory, University of Otago RCV001527377 SCV001738360 pathogenic Meier-Gorlin syndrome criteria provided, single submitter research
Labcorp Genetics (formerly Invitae), Labcorp RCV003718401 SCV004506402 uncertain significance not provided 2023-09-20 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects DONSON function (PMID: 31784481). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DONSON protein function. ClinVar contains an entry for this variant (Variation ID: 1012222). This missense change has been observed in individual(s) with Meier-Gorlin syndrome (PMID: 31784481). This variant is present in population databases (no rsID available, gnomAD 0.01%). This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 224 of the DONSON protein (p.Pro224Ser).
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV004594271 SCV005086684 likely pathogenic Microcephaly, short stature, and limb abnormalities 2023-12-21 criteria provided, single submitter clinical testing Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with microcephaly, short stature, and limb abnormalities (MIM#617604) and microcephaly-micromelia syndrome (MIM#251230). (I) 0106 - This gene is associated with autosomal recessive disease. However there has been one previous report of an individual with femoral facial syndrome who was heterozygous for a single DONSON variant (PMID: 31407851). (I) 0200 - Variant is predicted to result in a missense amino acid change from proline to serine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v3) <0.01 for a recessive condition (4 heterozygotes, 0 homozygotes). (SP) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0803 - This variant has limited previous evidence of pathogenicity in an unrelated individual. This variant has been observed as compound heterozygous in an individual with DONSON-related features in the literature, and was classified as pathogenic by a clinical laboratory in ClinVar in this same individual (PMID: 31784481). (SP) 1002 - This variant has moderate functional evidence supporting abnormal protein function. In transfected HeLa cells this variant was shown to have diffuse protein cellular localisation compared to wild type protein which was localised in the nucleus (PMID: 31784481). However, other studies in DONSON depleted cells have shown that this variant was able to rescue the cells' ability to synthesise DNA (PMID: 37638758) (SP) 1201 - Heterozygous variant detected in trans with a second likely pathogenic heterozygous variant (NM_017613.3:c.876C>G; p.(Phe292Leu)) in a recessive disease. (SP) 1206 - This variant has been shown to be paternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.